Literature DB >> 30408796

Relation between Early Over- and Undertreatment and Behavioural Problems in Preadolescent Children with Congenital Hypothyroidism.

Jacoba J Bongers-Schokking1, Wilma C M Resing2, Wilma Oostdijk3, Yolanda B de Rijke4, Sabine M P F de Muinck Keizer-Schrama5.   

Abstract

OBJECTIVE: Congenital hypothyroidism (CH) per se, when not treated or undertreated, may lead to severe behavioural problems (cretinism), whereas overtreatment of CH seems associated with attention problems. DESIGN AND METHODS: For 55 CH patients, prospectively followed from birth until 11 years, parents rated the Child Behaviour Checklist and teachers the Teacher's Report Form at children's ages 6 and 11 years. We related scores regarding Attention, Delinquency, and Aggression (ADA scores, indicative for attention deficit hyperactivity syndrome, ADHD), and scores regarding Withdrawn, Anxious, Social, and Thought problems (WAST scores, indicative for autism) to the occurrence of over- and undertreatment in five age periods. Over- and undertreatment were defined as free thyroxine (fT4) concentrations above/below the range of the patient's individual fT4 steady state concentration.
RESULTS: ADA scores at 6 and 11 years for patients overtreated in the period 1-3 months postnatally were higher than those for patients who were not overtreated. Patients with severe CH undertreated in the period 3-6 months postnatally had higher WAST scores at 6 and 11 years than all other patients.
CONCLUSIONS: This is the first study suggesting that permanent ADHD as well as autism in CH patients at ages 6 and 11 years are the result of early overtreatment and undertreatment, respectively.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  ADHD; Autism; Congenital hypothyroidism; Early overtreatment; Early undertreatment; fT4 steady state concentrations

Mesh:

Year:  2018        PMID: 30408796      PMCID: PMC6492506          DOI: 10.1159/000494056

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  11 in total

1.  Hypothyroxinemia in Preterm Neonates: Not Always Hypothyroidism.

Authors:  Vijayalakshmi Bhatia
Journal:  Indian J Pediatr       Date:  2019-06-19       Impact factor: 1.967

Review 2.  Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism.

Authors:  Andrew J Bauer; Ari J Wassner
Journal:  Endocrine       Date:  2019-07-26       Impact factor: 3.633

3.  Congenital hypothyroidism as a risk factor for hearing and parents' knowledge about its impact on hearing.

Authors:  Hélida Braga; Josilene Luciene Duarte; Luciene da Cruz Fernandes; Iza Cristina Salles; Caio L Oliveira de Andrade; Helton E Ramos; Crésio de Aragão D Alves
Journal:  J Otol       Date:  2020-09-11

4.  Primary Congenital Hypothyroidism in Children Below 3 Years Old - Etiology and Treatment With Overtreatment and Undertreatment Risks, a 5-Year Single Centre Experience.

Authors:  Elżbieta Lipska; Agnieszka Lecka-Ambroziak; Daniel Witkowski; Katarzyna Szamotulska; Ewa Mierzejewska; Mariusz Ołtarzewski
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-27       Impact factor: 6.055

5.  Referrals for Elevated Thyroid Stimulating Hormone to Pediatric Endocrinologists.

Authors:  Sarah Gammons; Brent K Presley; Perrin C White
Journal:  J Endocr Soc       Date:  2019-09-16

6.  Validity of Six Month L-Thyroxine Dose for Differentiation of Transient or Permanent Congenital Hypothyroidism

Authors:  Muhammet Asena; Meliha Demiral; Edip Unal; Murat Öcal; Hüseyin Demirbilek; Mehmet Nuri Özbek
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-01-28

Review 7.  Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology.

Authors:  Paul van Trotsenburg; Athanasia Stoupa; Juliane Léger; Tilman Rohrer; Catherine Peters; Laura Fugazzola; Alessandra Cassio; Claudine Heinrichs; Veronique Beauloye; Joachim Pohlenz; Patrice Rodien; Regis Coutant; Gabor Szinnai; Philip Murray; Beate Bartés; Dominique Luton; Mariacarolina Salerno; Luisa de Sanctis; Mariacristina Vigone; Heiko Krude; Luca Persani; Michel Polak
Journal:  Thyroid       Date:  2021-03       Impact factor: 6.568

8.  Comparison Among Two Liquid Formulations of L-thyroxine in the Treatment of Congenital Hypothyroidism in the First Month of Life: A Pilot Study.

Authors:  Gerdi Tuli; Jessica Munarin; Luisa de Sanctis
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-05       Impact factor: 6.055

Review 9.  An Overview on Different L-Thyroxine (l-T4) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.

Authors:  Stefano Stagi; Giovanna Municchi; Marta Ferrari; Malgorzata Gabriela Wasniewska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

Review 10.  Neuropsychological Alterations in Patients with Congenital Hypothyroidism Treated with Levothyroxine: Linked Factors and Thyroid Hormone Hyposensitivity.

Authors:  Karla Cristina Razón-Hernández; Norma Osnaya-Brizuela; Armando Valenzuela-Peraza; Esperanza Ontiveros-Mendoza; Luis Miguel Rodríguez-Serrano; Jorge Pacheco-Rosado; Gerardo Barragán-Mejía; Karla Sánchez-Huerta
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.